BioXcel Therapeutics (BTAI) Debt to Equity (2017 - 2026)
BioXcel Therapeutics (BTAI) debt to equity from Mar 29, 2017 to Mar 31, 2026. The current BioXcel Therapeutics (BTAI) debt to equity is -95.03%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of BioXcel Therapeutics (BTAI)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | -114.80% | +4.26% |
| 2024 | -110.11% | -38.15% |
| 2023 | -178.02% | -246.89% |
| 2022 | 121.19% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
Comparison BioXcel Therapeutics (BTAI) debt to equity with competitors
BioXcel Therapeutics (BTAI) debt to equity is -95.03%.